SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity.
Resource URI: https://dblp.l3s.de/d2r/resource/publications/journals/jcisd/GolcukHYTYG22
Home
|
Example Publications
Property
Value
dcterms:
bibliographicCitation
<
http://dblp.uni-trier.de/rec/bibtex/journals/jcisd/GolcukHYTYG22
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Ahmet_Yildiz
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Aysima_Hacisuleyman
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Elhan_Taka
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Mert_Golcuk
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Mert_Gur
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Sema_Zeynep_Yilmaz
>
foaf:
homepage
<
http://dx.doi.org/doi.org%2F10.1021%2Facs.jcim.1c01523
>
foaf:
homepage
<
https://doi.org/10.1021/acs.jcim.1c01523
>
dc:
identifier
DBLP journals/jcisd/GolcukHYTYG22
(xsd:string)
dc:
identifier
DOI doi.org%2F10.1021%2Facs.jcim.1c01523
(xsd:string)
dcterms:
issued
2022
(xsd:gYear)
swrc:
journal
<
https://dblp.l3s.de/d2r/resource/journals/jcisd
>
rdfs:
label
SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity.
(xsd:string)
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Ahmet_Yildiz
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Aysima_Hacisuleyman
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Elhan_Taka
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Mert_Golcuk
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Mert_Gur
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Sema_Zeynep_Yilmaz
>
swrc:
number
10
(xsd:string)
swrc:
pages
2490-2498
(xsd:string)
owl:
sameAs
<
http://bibsonomy.org/uri/bibtexkey/journals/jcisd/GolcukHYTYG22/dblp
>
owl:
sameAs
<
http://dblp.rkbexplorer.com/id/journals/jcisd/GolcukHYTYG22
>
rdfs:
seeAlso
<
http://dblp.uni-trier.de/db/journals/jcisd/jcisd62.html#GolcukHYTYG22
>
rdfs:
seeAlso
<
https://doi.org/10.1021/acs.jcim.1c01523
>
dc:
title
SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity.
(xsd:string)
dc:
type
<
http://purl.org/dc/dcmitype/Text
>
rdf:
type
swrc:Article
rdf:
type
foaf:Document
swrc:
volume
62
(xsd:string)